News

November 4, 2019November 4, 2019

PredictImmune’s IBD Test Soon Will Be Available in US, Canada, Across French-speaking Europe

News

Following product launches in the United Kingdom (UK) and Ireland earlier this year, the developer of the first validated test for inflammatory bowel disease (IBD) now has reached commercialization agreements ... Read more

October 29, 2019October 29, 2019

Arena Shares Full Data Supporting Etrasimod’s Long-term Safety and Efficacy

News

Arena Pharmaceuticals announced full long-term results of its OASIS extension study, confirming that once-daily oral etrasimod leads to sustained clinical responses and favorable safety for up to 46 weeks in ... Read more

October 28, 2019October 28, 2019

Excessive Steroid Use in IBD Patients Could Be Avoided in More than Half of Cases, Study Reports

News

People with inflammatory bowel disease (IBD) in the U.K. are commonly treated with corticosteroids, but a portion of these patients are treated excessively with steroids — and more than half ... Read more

October 25, 2019October 25, 2019

One-year Data Support Efficacy and Safety of Abivax’s ABX464 for Ulcerative Colitis

News

Abivax has announced data from a long-term trial that continues to support the efficacy and safety of its investigational oral treatment ABX464 for ulcerative colitis (UC). One year of treatment ... Read more

October 22, 2019October 22, 2019

Stelara Approved in US to Treat Moderate-to-Severe Ulcerative Colitis

News

The U.S. Food and Drug Administration (FDA) has approved Stelara (ustekinumab) for the treatment of adults with ulcerative colitis (UC) that is moderately to severely active, Janssen Pharmaceuticals, Stelara’s developer and ... Read more

October 21, 2019October 21, 2019

Pediatric-onset IBD Patients Experience More Severe Disease Than Those Diagnosed as Adults, Population-Based Study Says

News

Patients whose symptoms of inflammatory bowel disease (IBD) first appeared during their childhood usually experience more severe disease compared with those whose symptoms started later in adulthood, a study has ... Read more

October 18, 2019October 18, 2019

Gali Health Introduces Intelligent Personal Assistant for IBD Patients

News

To help people with inflammatory bowel disease (IBD) manage the complex and unpredictable disorder, Gali Health has introduced an artificial intelligence (AI)-powered personal health assistant. The free application for iOS ... Read more

October 16, 2019October 16, 2019

Caregivers of People Living with IBD Need Better Support, National Survey Finds

News

Results from a national survey highlight the heavy burden inflammatory bowel disease (IBD) places on patients’ family and friends, and the need for new strategies to provide better support to ... Read more

October 14, 2019October 14, 2019

Prometheus and Takeda Collaborate on Development of Targeted IBD Therapies

News

Biopharmaceutical company Prometheus Biosciences is collaborating with pharmaceutical firm Takeda to discover, develop, and commercialize a new generation of targeted therapies for inflammatory bowel disease (IBD). The global, multi-target strategic ... Read more

October 9, 2019October 9, 2019

Interim Analysis Suggests Wider-than-expected Dosing Range for IMU-838 to Treat Ulcerative Colitis

News

Interim analysis of a Phase 2 clinical trial that’s investigating IMU-838 in people with ulcerative colitis (UC) suggests a broader dose range than initially anticipated, announced the therapy’s developer, Immunic ... Read more